Shulph Ink
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
💎 Earn 597 Points (£5.97) on this item.
YOU SAVE £15.53
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £3.89. Subject to product weight & dimension
Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.
Couldn't load pickup availability
- More about Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
The book "Autoimmunity, COVID-19, Post-COVID-19 Syndrome, and COVID-19 Vaccination" covers the association between SARS-CoV-2 and autoimmune manifestations, including over 15 distinct autoantibodies and 10 different autoimmune diseases. It highlights the need to recognize these manifestations to cope with the ongoing pandemic and long-term post-pandemic period.
Format: Paperback / softback
Length: 830 pages
Publication date: 15 December 2022
Publisher: Elsevier Science Publishing Co Inc
The COVID-19 pandemic has brought forth a significant health crisis, impacting modern medicine like never before. The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised profound concerns regarding the potential link between the virus and various autoimmune manifestations. Extensive research has revealed that COVID-19 patients develop over 15 distinct autoantibodies and more than 10 different autoimmune diseases. Furthermore, evidence from recovered COVID-19 patients indicates the presence of persistent systemic symptoms, believed to have an autoimmune-related mechanism. Recognizing these autoimmune manifestations of COVID-19 and post-COVID-19 syndrome is of utmost importance in navigating the ongoing pandemic and the long-term post-pandemic period. This book serves as a crucial resource for the medical community, fulfilling a vital need in understanding and addressing these complex health challenges.
The COVID-19 pandemic has brought forth a significant health crisis, impacting modern medicine like never before. The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised profound concerns regarding the potential link between the virus and various autoimmune manifestations. Extensive research has revealed that COVID-19 patients develop over 15 distinct autoantibodies and more than 10 different autoimmune diseases. Furthermore, evidence from recovered COVID-19 patients indicates the presence of persistent systemic symptoms, believed to have an autoimmune-related mechanism. Recognizing these autoimmune manifestations of COVID-19 and post-COVID-19 syndrome is of utmost importance in navigating the ongoing pandemic and the long-term post-pandemic period. This book serves as a crucial resource for the medical community, fulfilling a vital need in understanding and addressing these complex health challenges.
COVID-19 has brought forth a health crisis that has impacted modern medicine like never before. The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised concerns about the potential link between the virus and various autoimmune manifestations. Extensive research has revealed that COVID-19 patients develop over 15 distinct autoantibodies and more than 10 different autoimmune diseases. Furthermore, evidence from recovered COVID-19 patients indicates the presence of persistent systemic symptoms, believed to have an autoimmune-related mechanism. Recognizing these autoimmune manifestations of COVID-19 and post-COVID-19 syndrome is crucial in navigating the ongoing pandemic and the long-term post-pandemic period. This book serves as a vital resource for the medical community, fulfilling a crucial need in understanding and addressing these complex health challenges.
Weight: 450g
Dimension: 235 x 191 (mm)
ISBN-13: 9780443185663
UK and International shipping information
UK and International shipping information
We deliver throughout the United Kingdom and to 128 countries and territories worldwide, including the United States, Australia, Canada, Germany, Spain and France.
